ZOSTAVAX
- Product NDC
- 0006-4963
- 11-digit product format
- 000064963
- Labeler code
- 0006
- Product ID
- 0006-4963_4608a61b-13c5-44f0-b3fd-eab84bf16b92
- Type
- VACCINE
- Nonproprietary name
- Zoster Vaccine Live
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
- Route
- SUBCUTANEOUS
- Labeler
- Merck Sharp & Dohme LLC
- Application
- BLA125123
- Marketing category
- BLA
- Marketing start
- 2006-05-25
- Marketing end
- 0000-00-00
- Substance
- VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN
- Active strength
- 19400 [PFU]/.65mL
- Pharmacologic classes
- Actively Acquired Immunity [PE], Chickenpox Vaccine [CS], Herpes Zoster Vaccine [CS], Live Attenuated Herpes Zoster Virus Vaccine [EPC], Live Attenuated Varicella Zoster Virus Vaccine [EPC], Vaccines, Attenuated [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0006-4963-00 | 00006496300 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-4963-00) > .65 mL in 1 VIAL, SINGLE-DOSE (0006-4963-01) | 2006-05-25 | 0000-00-00 | No | No | Current |
| 0006-4963-41 | 00006496341 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4963-41) > .65 mL in 1 VIAL, SINGLE-DOSE (0006-4963-01) | 2006-05-25 | 0000-00-00 | No | No | Current |